BHVI Launches Myopia Awareness Week 2023

May 1, 2023

Keep your eye on myopia is the message for #MyopiaAwarenessWeek 2023, with a call to ECPs to include myopia treatment as an essential part of their patients’ eye health care.

SYDNEY, Australia, May 1, 2023 – We are excited to announce the launch of Myopia Awareness Week for 2023 – a global initiative started in 2018, to bring attention to the growing epidemic of myopia in children across the world.

This year, Myopia Awareness Week will run from May 22-26. A range of educational and awareness resources for practitioners, parents and advocates of myopia awareness will again be provided by BHVI and its supporters with a focus this year on making myopia management an essential part of child eye health.

This year, BHVI is asking ECPs, parents and advocates to ‘Keep An Eye On Myopia’ – promoting the need to make myopia management essential for children, to aid in the global effort to slow the progression of myopia.

With treatment options advancing every year, and increasing findings from leading bodies like the International Myopia Institute and GMAC it is time for ECPs to include myopia management as an essential part of patient eye health. Enabling ECPs to easily understand what treatment options are available, alongside knowing what the symptoms, risks and prevalence are of myopia.

“At BHVI, we are thrilled to be able to bring together our sector during Myopia Awareness Week and work together on this global united effort.” said Rebecca Hodges, COO, BHVI.

Resources and campaign information can be found at


About BHVI

BHVI is an Australian not-for-profit organization with an international focus on vision research. Founded by the late Professor Brien Holden, its headquarters are located on the campus of its affiliate, the University of New South Wales (Kensington, Sydney, NSW). BHVI designs, translates and evaluates new technologies and enhances existing products. Its development portfolio includes vision correction designs that target myopia, presbyopia, hyperopia and astigmatism. BHVI also conducts research in dry eye and eye comfort. BHVI has a comprehensive intellectual property portfolio. It supports the ophthalmic sector with market development initiatives and myopia management education. For more information, visit

No citation data has been entered for this IMI Whitepaper